BioNexus Gene Lab
BGLC
#10184
Rank
NZ$8.17 M
Marketcap
$4.45
Share price
-2.20%
Change (1 day)
323.75%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2023 (TTM): -$0.07398

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -$0.07575. In 2022 the company made an earnings per share (EPS) of -$0.03992 a decrease over its 2021 EPS that were of $0.06047.

EPS history for BioNexus Gene Lab from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.0739885.32%
2022-$0.03992-166.02%
2021$0.06047-74.82%
2020$0.24-600.17%
2019-$0.04801

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.64 4,699.33%๐Ÿ‡บ๐Ÿ‡ธ USA